The generic injectables market in the Middle East & Africa is expected to grow from US$ 3,717.72 million in 2021 to US$ 6,616.77 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028.
The patents of branded injectables in several countries are likely to expire in the coming years, offering numerous remunerative opportunities to the generic injectables manufacturers. Additionally, manufacturers in the generic injectables market are becoming future-ready by maintaining adequate supply chains to prevent vulnerabilities, such as those caused by the COVID-19 outbreak. Zydus Cadila is significantly reducing the price of its generic version of Remdesivir, namely Remdac. Thus, the nearing expiry of patent validity of branded drugs is likely to provide significant opportunities to generic drug manufacturers, including the companies offering generic injectables.
Middle East & Africa Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Generic Injectables Market Segmentation
The Middle East & Africa generic injectables market is segmented into product type, container type, application, route of administration, and country. Based on product type, the market has been segmented into large molecule injectable and small molecule injectable. In 2020, the large molecule injectable segment held a larger market share. In terms of container type, the market has been categorized into vials, premix, prefilled syringes, ampoules, and others. In 2020, the vials segment held the largest share of the market. Based on application, the market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, and others. In 2020, the oncology segment held the largest share of the market. Based on route of administration, the market has been categorized into intravenous, intramuscular, subcutaneous, and others. In 2020, the intravenous segment held the largest market share. Based on country, the Middle East & Africa generic injectables market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia contributed a substantial share in 2020.
AstraZeneca; Baxter International Inc.; Biocon; Fresenius SE & Co. KGaA; GlaxoSmithKline plc; Hikma Pharmaceuticals PLC; Johnson and Johnson Services, Inc.; Lupin; Merck & Co., Inc.; Pfizer Inc.; and Viatris Inc are among the leading companies in the Middle East & Africa generic injectables market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 3,717.72 Million |
| Market Size by 2028 | US$ 6,616.77 Million |
| CAGR (2021 - 2028) | 8.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Generic Injectables Market is valued at US$ 3,717.72 Million in 2021, it is projected to reach US$ 6,616.77 Million by 2028.
As per our report Middle East and Africa Generic Injectables Market, the market size is valued at US$ 3,717.72 Million in 2021, projecting it to reach US$ 6,616.77 Million by 2028. This translates to a CAGR of approximately 8.6% during the forecast period.
The Middle East and Africa Generic Injectables Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Generic Injectables Market report:
The Middle East and Africa Generic Injectables Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Generic Injectables Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Generic Injectables Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Generic Injectables Market
